Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines

Inactivated coronavirus disease 2019 (COVID-19) vaccines such as CoronaVac and BBIBP-CorV have been widely used in China. However, more investigation is still needed to understand antibodies' duration and effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant...

Full description

Bibliographic Details

Published in:	Biosafety and Health
Main Authors:	Ziyu Liu, Liyan Cai, Man Xing, Nan Qiao, Jiaojiao Liu, Xuejun Li, Chiyu Zhang, Naijun Tang, Zhelong Xu, Yingying Guo, Renfei Lu, Dongming Zhou
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Subjects:	Variant of concern (VOC) Inactivated vaccines Serological study IgG subclasses Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Online Access:	http://www.sciencedirect.com/science/article/pii/S259005362400051X